{"id":"https://openalex.org/W4205616623","doi":"https://doi.org/10.1200/jco.2022.40.4_suppl.609","title":"Homologous recombination repair pathway alterations and their relationship to homologous recombination deficiency in advanced pancreatic cancer patients.","display_name":"Homologous recombination repair pathway alterations and their relationship to homologous recombination deficiency in advanced pancreatic cancer patients.","publication_year":2022,"publication_date":"2022-01-19","ids":{"openalex":"https://openalex.org/W4205616623","doi":"https://doi.org/10.1200/jco.2022.40.4_suppl.609"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2022.40.4_suppl.609","doi":"https://doi.org/10.1200/jco.2022.40.4_suppl.609","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.4_suppl.609","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Hitendra Patel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hitendra Patel","raw_affiliation_strings":["University of California San Diego Moores Cancer Center, La Jolla, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California San Diego Moores Cancer Center, La Jolla, CA;","institution_ids":["https://openalex.org/I4390039236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062139399","display_name":"Alex Barrett","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114883","display_name":"Tempus Labs (United States)","ror":"https://ror.org/01gbymr57","country_code":"US","type":"company","lineage":["https://openalex.org/I4210114883"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alex Barrett","raw_affiliation_strings":["Tempus Labs, Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tempus Labs, Chicago, IL;","institution_ids":["https://openalex.org/I4210114883"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103204223","display_name":"Elizabeth A. Mauer","orcid":"https://orcid.org/0009-0001-8033-0696","observed_orcids":["https://orcid.org/0009-0001-8033-0696","https://orcid.org/0000-0002-9012-0502"]},"institutions":[{"id":"https://openalex.org/I4210114883","display_name":"Tempus Labs (United States)","ror":"https://ror.org/01gbymr57","country_code":"US","type":"company","lineage":["https://openalex.org/I4210114883"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth Mauer","raw_affiliation_strings":["Tempus Labs, Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tempus Labs, Chicago, IL;","institution_ids":["https://openalex.org/I4210114883"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086626483","display_name":"Shumei Kato","orcid":"https://orcid.org/0000-0003-1193-1815","observed_orcids":["https://orcid.org/0000-0003-1193-1815"]},"institutions":[{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shumei Kato","raw_affiliation_strings":["University of California San Diego, Moores Cancer Center, La Jolla, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California San Diego, Moores Cancer Center, La Jolla, CA;","institution_ids":["https://openalex.org/I4390039236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029286783","display_name":"Benjamin D. Leibowitz","orcid":"https://orcid.org/0000-0002-0535-5463","observed_orcids":["https://orcid.org/0000-0002-0535-5463"]},"institutions":[{"id":"https://openalex.org/I4210114883","display_name":"Tempus Labs (United States)","ror":"https://ror.org/01gbymr57","country_code":"US","type":"company","lineage":["https://openalex.org/I4210114883"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Benjamin D. Leibowitz","raw_affiliation_strings":["Tempus Labs, Inc., Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tempus Labs, Inc., Chicago, IL;","institution_ids":["https://openalex.org/I4210114883"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023598971","display_name":"Aatur Dilip Singhi","orcid":"https://orcid.org/0000-0003-3930-7096","observed_orcids":["https://orcid.org/0000-0003-3930-7096"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aatur D. Singhi","raw_affiliation_strings":["Department of Pathology, University of Pittsburgh, Pittsburgh, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, University of Pittsburgh, Pittsburgh, PA;","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054771911","display_name":"Milind M. Javle","orcid":"https://orcid.org/0000-0001-9158-0941","observed_orcids":["https://orcid.org/0000-0001-9158-0941"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Milind M. Javle","raw_affiliation_strings":["University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089839809","display_name":"Andrew M. Lowy","orcid":"https://orcid.org/0000-0002-7106-0735","observed_orcids":["https://orcid.org/0000-0002-7106-0735"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew M. Lowy","raw_affiliation_strings":["UCSD Moores Cancer Center, La Jolla, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCSD Moores Cancer Center, La Jolla, CA;","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"4_suppl","first_page":"609","last_page":"609"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.8438000082969666,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.8438000082969666,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.0925000011920929,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.0421999990940094,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/homologous-recombination-repair","display_name":"homologous recombination repair","score":0.8840000033378601},{"id":"https://openalex.org/keywords/homologous-recombination-deficiency","display_name":"homologous recombination deficiency","score":0.9980000257492065},{"id":"https://openalex.org/keywords/advanced-pancreatic-cancer","display_name":"advanced pancreatic cancer","score":0.8690000176429749},{"id":"https://openalex.org/keywords/brca-mutations","display_name":"BRCA mutations","score":0.8059999942779541},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.734000027179718},{"id":"https://openalex.org/keywords/loss-of-heterozygosity","display_name":"loss of heterozygosity","score":0.9070000052452087},{"id":"https://openalex.org/keywords/chek2","display_name":"CHEK2","score":0.40799999237060547},{"id":"https://openalex.org/keywords/attenuated-total-reflectance","display_name":"ATR","score":0.4620000123977661},{"id":"https://openalex.org/keywords/dna-damage-response","display_name":"DNA damage response","score":0.42399999499320984},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.7559999823570251},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.38199999928474426}],"concepts":[{"id":"https://openalex.org/C102744134","wikidata":"https://www.wikidata.org/wiki/Q22280388","display_name":"Homologous recombination","level":3,"score":0.8397825956344604},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.6647263169288635},{"id":"https://openalex.org/C143589142","wikidata":"https://www.wikidata.org/wiki/Q2617554","display_name":"Loss of heterozygosity","level":4,"score":0.6303462982177734},{"id":"https://openalex.org/C2778144015","wikidata":"https://www.wikidata.org/wiki/Q18046302","display_name":"PALB2","level":5,"score":0.582843542098999},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.5632545351982117},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.517310380935669},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5110489130020142},{"id":"https://openalex.org/C2779138821","wikidata":"https://www.wikidata.org/wiki/Q7118227","display_name":"PARP inhibitor","level":5,"score":0.5109495520591736},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5046709775924683},{"id":"https://openalex.org/C64894306","wikidata":"https://www.wikidata.org/wiki/Q849622","display_name":"Homologous chromosome","level":3,"score":0.5042835474014282},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4638509750366211},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.3883044719696045},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.36648058891296387},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.35533809661865234},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.34882599115371704},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.31563836336135864},{"id":"https://openalex.org/C180754005","wikidata":"https://www.wikidata.org/wiki/Q80726","display_name":"Allele","level":3,"score":0.2779049277305603},{"id":"https://openalex.org/C13514818","wikidata":"https://www.wikidata.org/wiki/Q5552256","display_name":"Germline mutation","level":4,"score":0.18814444541931152},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.12948578596115112}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2022.40.4_suppl.609","doi":"https://doi.org/10.1200/jco.2022.40.4_suppl.609","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.4_suppl.609","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4379281620","https://openalex.org/W4410737378","https://openalex.org/W3171975997","https://openalex.org/W4390232300","https://openalex.org/W4388979824","https://openalex.org/W4410816801","https://openalex.org/W2599376208","https://openalex.org/W4379282753","https://openalex.org/W3200900608","https://openalex.org/W4361284586"],"abstract_inverted_index":{"609":[0],"Background:":[1],"Homologous":[2],"recombination":[3,41],"repair":[4],"(HRR)":[5],"is":[6,46],"critical":[7,79],"for":[8,290],"limiting":[9],"DNA":[10],"damage":[11],"arising":[12],"from":[13,91,312],"double":[14],"strand":[15],"breaks.":[16],"Disrupting":[17],"HRR":[18,65,141,188,201,216,263,320],"has":[19],"emerged":[20],"as":[21],"a":[22,54,78,171,195],"therapeutic":[23],"strategy":[24],"in":[25,52,63,82,165,174,182,198,211,258,275,303,318,331],"pancreatic":[26,96,149,336],"cancer":[27,97,150,337],"given":[28],"the":[29,83,105,266,326],"development":[30],"of":[31,57,68,109,124,220,225,230,235,242,328,334],"PARP":[32,75,313,329],"inhibitors":[33],"that":[34,71,98,252,272,300],"can":[35],"specifically":[36],"target":[37],"tumors":[38,161],"with":[39,49,94,104,286],"homologous":[40],"deficiency":[42],"(HRD).":[43],"While":[44],"HRD":[45,156,221],"strongly":[47],"associated":[48,285],"loss-of-function":[50],"mutations":[51],"BRCA1/2,":[53],"broad":[55],"range":[56],"pathogenic":[58,69,209],"alterations":[59,70,136,164,181,210,274,308,317],"have":[60],"been":[61],"identified":[62,146],"other":[64,140,186,200,215,236,243,262,267,319],"genes.":[66,143,217,321],"Identification":[67],"predict":[72],"response":[73],"to":[74,137,152,316],"inhibition":[76,314,330],"remains":[77],"knowledge":[80],"gap":[81],"field.":[84],"Methods:":[85],"We":[86,145,248],"retrospectively":[87],"analyzed":[88],"de-identified":[89],"records":[90],"895":[92],"patients":[93,151,305],"advanced":[95],"underwent":[99],"next":[100],"generation":[101],"sequencing":[102],"(NGS)":[103],"Tempus|xT":[106],"assay":[107],"(DNA-seq":[108],"648":[110],"genes":[111],"at":[112,183],"500x":[113],"coverage,":[114],"matched":[115],"normal,":[116],"full":[117],"transcriptome":[118],"RNA-seq).":[119],"HRD-positivity":[120,287],"and":[121,205,239,280],"genome-wide":[122],"loss":[123],"heterozygosity":[125],"(LOH)":[126],"were":[127,132,246,253,282],"compared":[128],"across":[129],"groups,":[130],"which":[131],"defined":[133],"based":[134],"on":[135],"BRCA1/2":[138,166,175,213,260],"or":[139,261],"pathway":[142],"Results:":[144],"293/895":[147],"(33%)":[148],"be":[153],"HRD-positive.":[154,247],"Among":[155],"positive":[157],"patients,":[158],"23/895":[159],"(2.6%)":[160],"harbored":[162,170,179,194],"two":[163,180],"(BRCA++),":[167],"179/895":[168],"(20%)":[169],"single":[172,196,273],"alteration":[173,197,257],"(BRCA+),":[176],"25/895":[177],"(2.8%)":[178],"least":[184],"one":[185,199],"non-BRCA":[187],"gene":[189,202],"(other":[190,203],"HRR++),":[191],"367/895":[192],"(41%)":[193],"HRR+),":[204],"143/895":[206],"(16%)":[207,234],"had":[208],"neither":[212],"nor":[214],"In":[218],"terms":[219],"status,":[222],"23/23":[223],"(100%)":[224],"BRCA++":[226],"cases,":[227,232,238],"179/337":[228],"(53%)":[229],"BRCA+":[231],"4/25":[233],"HRR++":[237],"87/367":[240],"(24%)":[241],"HRR+":[244,268,335],"cases":[245,251],"observed":[249],"no":[250],"HRD-positive":[254],"without":[255,306],"an":[256],"either":[259],"gene.":[264],"Within":[265],"group,":[269],"we":[270],"found":[271],"CHEK1/2,":[276],"FANCA/L,":[277],"MRE11,":[278],"PALB2,":[279],"RAD51B":[281],"all":[283],"significantly":[284],"whereas":[288],"CDK12,":[289],"instance,":[291],"was":[292],"not":[293],"(Table).":[294],"Conclusions:":[295],"Comprehensive":[296],"genomic":[297],"profiling":[298],"demonstrates":[299],"approximately":[301],"1":[302],"4":[304],"BRCA":[307],"may":[309,324],"potentially":[310],"benefit":[311],"due":[315],"Future":[322],"studies":[323],"examine":[325],"role":[327],"this":[332],"population":[333],"patients.[Table:":[338],"see":[339],"text]":[340]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2022-01-25T00:00:00"}